Use access key #2 to skip to page content.
$10.30 -0.10 (-0.96%)
9/5/2008 4:00 PM

BioMimetic Therapeutics, Inc. (BMTI)

CAPS Rating:
**

The Company develops and commercializes bio-active drug-device combination products for the healing of musculoskeletal injuries and diseases, including periodontal, orthopedic, spine and sports injury applications.

View All Commentary (BMTI)

Recs

0

Avatar JonAtkins57 (57.28) Submitted: 5/27/08 3:38 PM : Outperform Start Price: $11.41 BMTI Score: 0.71

Market Cap: 100M - 1B
Dividend Yield (%): < 1
Net Profit Margin (%): >= 20
Gross Margin (%) >= 20
Current Ratio: >= 1
Last Price > 10 and < 12
EPS > 0

Report this Post Replies: 0 | Reply

Featured Broker Partners